Status:

NOT_YET_RECRUITING

Group Emotion-Focused Behavioral Intervention for Diabetes Distress/A1c in T2D.

Lead Sponsor:

Ohio State University

Collaborating Sponsors:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Conditions:

T2DM (Type 2 Diabetes Mellitus)

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

T2D is a major public health problem and is currently the 7th leading cause of death in the US. Despite a range of efficacious treatments, less than 50% of patients achieve a glycemic target of A1c \<...

Detailed Description

This is an early-stage treatment development project proposing to conduct a modest randomized clinical trial of Group EFBI, vs. a Group Attentional Control Intervention, to collect feasibility, accept...

Eligibility Criteria

Inclusion

  • Male and female adults with documented diagnosis of T2D for at least one year.
  • Age \> 18 years of age.
  • Diabetes Distress Scale score \> 2.0 on any DDS subscale.
  • A1c \> 7.5 (with hemoglobin in the normal range).
  • PHQ-9 Depression score \< 15.
  • Stable medical co-morbid conditions.
  • Absence of a psychotic disorder or an intellectual disability.
  • Able to read English.
  • Able to give informed consent.

Exclusion

  • Male and female adults with documented diagnosis of T2D for less than one year.
  • Age \< 18 years of age.
  • Diabetes Distress Scale score \< 2.0 on all DDS subscales.
  • A1c \< 7.5 (with hemoglobin in the normal range).
  • PHQ-9 Depression score \> 15.
  • Unstable medical co-morbid conditions (e.g., hospitalization in past three months).
  • Presence of a psychotic disorder or an intellectual disability.
  • Initiation of psychotherapy or pharmacotherapy for emotional issues within three months of study entry.
  • Unable to read English.
  • Unable to give informed consent.

Key Trial Info

Start Date :

September 1 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

January 31 2028

Estimated Enrollment :

120 Patients enrolled

Trial Details

Trial ID

NCT06912737

Start Date

September 1 2025

End Date

January 31 2028

Last Update

April 6 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

The Ohio State University Wexner Medical Center

Columbus, Ohio, United States, 43210